Seer (NASDAQ:SEER – Get Free Report) is projected to announce its Q3 2026 results after the market closes on Tuesday, November 10th. Analysts expect the company to announce earnings of ($0.26) per share and revenue of $4.15 million for the quarter. Individuals can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 4:30 PM ET.
Seer (NASDAQ:SEER – Get Free Report) last issued its quarterly earnings data on Tuesday, August 11th. The company reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.04). The firm had revenue of $3.10 million for the quarter, compared to analysts’ expectations of $3.55 million. Seer had a negative net margin of 478.05% and a negative return on equity of 27.23%.
Seer Price Performance
SEER opened at $1.73 on Tuesday. Seer has a one year low of $1.55 and a one year high of $2.38. The company has a fifty day moving average price of $2.00 and a 200-day moving average price of $1.92. The firm has a market capitalization of $95.79 million, a P/E ratio of -1.42 and a beta of 1.47.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Seer in a report on Thursday, October 15th. Two equities research analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $4.00.
View Our Latest Stock Report on Seer
Seer Company Profile
Seer, Inc is a life sciences company that develops technologies for large-scale protein analysis, known as proteomics. The company’s platform is designed to help researchers study a broad range of proteins in biological samples and generate detailed information that may support drug discovery, disease research and biomarker development.
Seer’s primary offering is the Proteograph Product Suite, which combines engineered nanoparticle technology, laboratory consumables, automation and software.
Further Reading
- Five stocks we like better than Seer
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
Receive News & Ratings for Seer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seer and related companies with MarketBeat.com's FREE daily email newsletter.
